ClinicalTrials.gg
Not yet recruitingNCT07131111Updated Aug 20, 2025

Impact of Aortic Geometry on Vascular Remodeling After Stent Implantation in Coarctation of the Aorta

An observational study in Aortic Geometry, Vascular Remodeling and Coarctation of Aorta, sponsored by Assiut University. Not yet recruiting at 1 site in Egypt. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-20.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
50
Ages
12 Years and older
Sex
All
01

Study summary

This study aims to assess:

  1. Aortic geometrical changes and their relationship to hypertension and cardiovascular events.
  2. Aortic geometrical differences between healthy individuals and patients with repaired coarctation of the aorta.
Read the detailed description

Coarctation of the aorta (CoA) is a congenital narrowing of the aortic lumen, accounting for 5-8% of congenital heart diseases, with an incidence of 1 in 3000-4000 live births . This narrowing leads to altered hemodynamics, including increased left ventricular afterload, systemic hypertension, and long-term vascular remodeling, which can persist even after anatomical correction .

Despite advances in interventions like stent implantation for native or recurrent CoA, many patients remain hypertensive post-procedure . This residual hypertension may not be purely mechanical but linked to persistent vascular dysfunction, abnormal aortic compliance, or inadequate aortic wall remodeling .

Aortic stiffness is now recognized as a key cardiovascular risk factor in CoA patients . Reduced elasticity contributes to high systolic blood pressure, increased cardiac workload, and late cardiovascular complications [7]. Moreover, abnormal aortic arch geometry-particularly the "gothic arch"-has been linked to impaired vascular function and unfavorable hemodynamics [13].

While cardiac magnetic resonance (CMR) is the standard for evaluating aortic stiffness and ventricular function , CT Aortography offers high-resolution images to assess aortic distensibility, luminal changes, and residual stenosis, especially post-stenting . When combined with blood pressure and ECG data, these insights can provide a fuller picture of outcomes .

This study investigates the relationship between post-stenting blood pressure and aortic geometry-including arch shape and residual stenosis-using CT Aortography in CoA patients. It also explores ECG changes as potential non-invasive markers of ventricular strain and hemodynamic stress ..

02

Conditions studied

  • Aortic Geometry
  • Vascular Remodeling
  • Coarctation of Aorta
  • Blood Pressure
  • Residual Stenosis
  • CT Aortography
  • CMR
  • Aortic Elasticity and Distensibility
  • Aortic Arch

Browse trials for

03

In context

Aortic Coarctation

49 studies on the registry are indexed under Aortic Coarctation; 16 are open to participants now.

This study's planned enrollment of 50 is below the median of 100 across 29 observational studies indexed under Aortic Coarctation.

Browse Aortic Coarctation studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study population will consist of two groups:

  1. Patients group: Individuals diagnosed with coarctation of the aorta (CoA) who have undergone successful stent implantation and will be evaluated six months post-stenting.
  2. Control group: Age- and sex-matched healthy volunteers with no history of cardiovascular or systemic diseases.

All participants will undergo imaging and functional evaluation including CT aortography, cardiac MRI, 24-hour ambulatory blood pressure monitoring (ABPM), and ECG as part of the study protocol.

The study will be conducted at [Assiut University Hospital / Orman Cardiology Center - modify as needed], and participants will be recruited from the cardiology outpatient clinics and imaging units.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age ≥ 12 years.

Diagnosed with native or recurrent coarctation of the aorta.

Transcatheter systolic pressure gradient ≥ 20 mmHg.

Body weight ≥ 20 kg.

Availability of pre- and post-stenting CT aortography data.

Exclusion criteria

Exclusion Criteria:

Patients with obstructive lesion of LVOT or aortic valve dysfunction greater than moderate (requiring surgical intervention)..

Patients with other causes of secondary hypertension.

Associated complex congenital heart defects (aside from simple septal defects and patent ductus arteriosus)

Genetic syndromes

Connective tissue disorder

History of surgery involving the aortic root or ascending aorta.

Incomplete imaging or missing data relevant to the study.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • COA patients

    Radiation: CT aortography · Radiation: CMR

  • Healthy controls

    Radiation: CT aortography

Interventions

  • RadiationCT aortography

    Performed before and after stenting using a multidetector CT scanner (device model and parameters to be specified). Analysis will include: * Evaluation of aortic arch geometry (normal / gothic / crenel). * Measurement of residual stenosis at the site of coarctation. * Aortic diameter measurements at predefined anatomical levels: Ascending aorta (AA), Proximal descending thoracic aorta (PDA), At the level of the diaphragm (DA), Abdominal aorta (AbAo). \- Aortic tortuosity. All CT data will be interpreted by two independent observers blinded to clinical outcomes

  • RadiationCMR

    CMR examinations will be performed using a commercially available 1.5 Tesla whole-body scanner (Ingenia, Philips Healthcare, release 4.1.3.0). In pediatric or uncooperative patients, free-breathing sequences were used when breath-holding was not feasible. Brachial blood pressure was measured in the right arm in the supine position immediately before image acquisition using automated oscillometric devices. Cine steady-state free precession (SSFP) sequences were obtained in multiple views including the short axis of the ascending aorta (AAO) and descending aorta (DAO), as well as the aortic root to evaluate aortic valve morphology (bicuspid vs tricuspid). Left ventricular (LV) and left atrial (LA) functional parameters were assessed by standard volumetric analysis. The following CMR-derived parameters were collected: Left ventricular ejection fraction (LVEF) Left ventricular strain Left ventricular mass index (LVMI) Left atrial volume Left atrial strain LV and LA strain were analyzed usi

06

What researchers measure

Primary outcomes

  1. Change in Systolic Blood Pressure

    Difference in systolic blood pressure between baseline (pre-stenting) and 6 months post-stenting using standardized clinical sphygmomanometer. Unit of Measure: mmHg

    Time frame: Baseline and 6 months post-stenting

  2. Change in Diastolic Blood Pressure

    Difference in diastolic blood pressure between baseline (pre-stenting) and 6 months post-stenting using standardized clinical sphygmomanometer. Unit of Measure: mmHg

    Time frame: Baseline and 6 months post-stenting

Secondary outcomes

  1. Aortic Arch Morphology Classification

    Classification of aortic arch morphology (normal, gothic, crenel) based on CT aortography. Unit of Measure: Categorical (normal/gothic/crenel)

    Time frame: Baseline (within hospital stay, up to 2 days)

  2. Aortic Elasticity

    Aortic elasticity calculated from CT aortography using (ΔA/A)/ΔP, where A is cross-sectional area and P is pulse pressure. Unit of Measure: mm²/mmHg

    Time frame: Baseline and 6 months post-stenting

  3. Aortic Distensibility

    Aortic distensibility measured from CT aortography. Unit of Measure: mmHg-¹

    Time frame: Baseline and 6 months post-stenting

  4. Aortic Arch Angle

    Aortic arch angle measured from CT aortography. Unit of Measure: degrees

    Time frame: Baseline and 6 months post-stenting

  5. Aortic Arch Curvature

    Curvature of the aortic arch measured from CT aortography. Unit of Measure: cm-¹

    Time frame: Baseline and 6 months post-stenting

  6. Residual Stenosis

    Percentage of luminal narrowing remaining after stent implantation measured by CT angiography. Unit of Measure: %

    Time frame: 6 months post-stenting

  7. Left Ventricular Ejection Fraction (LVEF)

    Description: LVEF measured by cardiac MRI. Unit of Measure: %

    Time frame: Baseline and 6 months post-stenting

  8. LV Global Longitudinal Strain

    LV global longitudinal strain measured by cardiac MRI. Unit of Measure: %

    Time frame: Baseline and 6 months post-stenting

  9. LV Mass Index (LVMI)

    LV mass indexed to body surface area measured by cardiac MRI. Unit of Measure: g/m²

    Time frame: Baseline and 6 months post-stenting

  10. Left Atrial Volume Index (LAVI)

    Description: Left atrial volume indexed to body surface area measured by cardiac MRI. Unit of Measure: mL/m²

    Time frame: Baseline and 6 months post-stenting

  11. QTc Dispersion

    QTc dispersion measured from 12-lead ECG using Bazett's formula. Unit of Measure: milliseconds

    Time frame: Baseline and 6 months post-stenting

  12. Presence of Left Ventricular Hypertrophy on ECG

    Detection of LV hypertrophy based on standard ECG voltage criteria. Unit of Measure: Categorical (present/absent)

    Time frame: Baseline and 6 months post-stenting

  13. Presence of Arrhythmia

    Detection of arrhythmias using standard 12-lead ECG or Holter monitoring. Unit of Measure: Categorical (present/absent)

    Time frame: Baseline and 6 months post-stenting

07

Study locations

1 site
  • Institutional Review Board (IRB) of Faculty of Medicine
    Asyut, Egypt
08

References and documents

Publications

  • Shepherd B, Abbas A, McParland P, Fitzsimmons S, Shambrook J, Peebles C, Brown I, Harden S. MRI in adult patients with aortic coarctation: diagnosis and follow-up. Clin Radiol. 2015 Apr;70(4):433-45. doi: 10.1016/j.crad.2014.12.005. Epub 2015 Jan 3. PubMed 25559379 ↗
  • Toro-Salazar OH, Steinberger J, Thomas W, Rocchini AP, Carpenter B, Moller JH. Long-term follow-up of patients after coarctation of the aorta repair. Am J Cardiol. 2002 Mar 1;89(5):541-7. doi: 10.1016/s0002-9149(01)02293-7. PubMed 11867038 ↗
  • Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia G; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008 Aug;26(8):1505-26. doi: 10.1097/HJH.0b013e328308da66. PubMed 18622223 ↗
  • Iriart X, Laik J, Cremer A, Martin C, Pillois X, Jalal Z, Roubertie F, Thambo JB. Predictive factors for residual hypertension following aortic coarctation stenting. J Clin Hypertens (Greenwich). 2019 Feb;21(2):291-298. doi: 10.1111/jch.13452. Epub 2018 Dec 25. PubMed 30585428 ↗
  • Pushparajah K, Duong P, Mathur S, Babu-Narayan S. EDUCATIONAL SERIES IN CONGENITAL HEART DISEASE: Cardiovascular MRI and CT in congenital heart disease. Echo Res Pract. 2019 Oct 1;6(4):R121-38. doi: 10.1530/ERP-19-0048. Online ahead of print. PubMed 31730044 ↗
  • Faganello G, Cioffi G, Rossini M, Ognibeni F, Giollo A, Fisicaro M, Russo G, Di Nora C, Doimo S, Tarantini L, Mazzone C, Cherubini A, D'Agata Mottolesi B, Pandullo C, Di Lenarda A, Sinagra G, Viapiana O. Are aortic coarctation and rheumatoid arthritis different models of aortic stiffness? Data from an echocardiographic study. Cardiovasc Ultrasound. 2018 Jun 26;16(1):9. doi: 10.1186/s12947-018-0126-y. PubMed 29940971 ↗
  • Agasthi P, Pujari SH, Tseng A, Graziano JN, Marcotte F, Majdalany D, Mookadam F, Hagler DJ, Arsanjani R. Management of adults with coarctation of aorta. World J Cardiol. 2020 May 26;12(5):167-191. doi: 10.4330/wjc.v12.i5.167. PubMed 32547712 ↗
  • Ou P, Mousseaux E, Celermajer DS, Pedroni E, Vouhe P, Sidi D, Bonnet D. Aortic arch shape deformation after coarctation surgery: effect on blood pressure response. J Thorac Cardiovasc Surg. 2006 Nov;132(5):1105-11. doi: 10.1016/j.jtcvs.2006.05.061. PubMed 17059930 ↗
  • Ou P, Bonnet D, Auriacombe L, Pedroni E, Balleux F, Sidi D, Mousseaux E. Late systemic hypertension and aortic arch geometry after successful repair of coarctation of the aorta. Eur Heart J. 2004 Oct;25(20):1853-9. doi: 10.1016/j.ehj.2004.07.021. PubMed 15474701 ↗
  • Vonder Muhll IF, Sehgal T, Paterson DI. The Adult With Repaired Coarctation: Need for Lifelong Surveillance. Can J Cardiol. 2016 Aug;32(8):1038.e11-5. doi: 10.1016/j.cjca.2015.12.036. Epub 2016 Jan 21. PubMed 27084076 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07131111
Lead sponsor
Assiut University
Responsible party
Mina wadee fathy (Principal investigator, Assiut University) — Principal investigator
First posted
Aug 20, 2025
Start date
Sep 1, 2025 (estimated)
Primary completion
Sep 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 20, 2025

Study contacts

Mena Wadee, Resident doctor
Contact
menawade399@gmail.com
01282210873
Noha Gamal
Contact
noha_cardio@aun.edu.eg
+201002295166
Salwa Demitry Roshdy, Professor
study director · Faculty of medicine AssiutU university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion